Rituximab biosimilars: introduction into clinical practice

Lancet Haematol. 2017 Aug;4(8):e342-e343. doi: 10.1016/S2352-3026(17)30124-2. Epub 2017 Jul 14.

Authors

Shinichi Makita¹, Kensei Tobinai²

Affiliations

¹ Department of Hematology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
² Department of Hematology, National Cancer Center Hospital, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: ktobinai@ncc.go.jp.

PMID: 28712939
DOI: 10.1016/S2352-3026(17)30124-2

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biosimilar Pharmaceuticals*
Humans
Rituximab*

Substances

Biosimilar Pharmaceuticals
Rituximab